Bank of America’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-227,221
| Closed | -$4.42M | – | 7577 |
|
|
2018
Q1 | $4.42M | Buy |
227,221
+12,920
| +6% | +$254K | ﹤0.01% | 3192 |
|
|
2017
Q4 | $3.57M | Buy |
214,301
+25,671
| +14% | +$471K | ﹤0.01% | 3434 |
|
|
2017
Q3 | $3.83M | Sell |
188,630
-9,348
| -5% | -$179K | ﹤0.01% | 3423 |
|
|
2017
Q2 | $3.19M | Buy |
197,978
+10,585
| +6% | +$156K | ﹤0.01% | 3464 |
|
|
2017
Q1 | $2.37M | Buy |
187,393
+87,867
| +88% | +$1.06M | ﹤0.01% | 3729 |
|
|
2016
Q4 | $1.32M | Buy |
99,526
+34,216
| +52% | +$585K | ﹤0.01% | 4119 |
|
|
2016
Q3 | $1.55M | Buy |
65,310
+10,012
| +18% | +$269K | ﹤0.01% | 3844 |
|
|
2016
Q2 | $1.59M | Sell |
55,298
-2,820
| -5% | -$91.9K | ﹤0.01% | 3820 |
|
|
2016
Q1 | $1.86M | Buy |
58,118
+18,577
| +47% | +$653K | ﹤0.01% | 3628 |
|
|
2015
Q4 | $1.69M | Sell |
39,541
-2,359
| -6% | -$94.2K | ﹤0.01% | 3943 |
|
|
2015
Q3 | $1.48M | Sell |
41,900
-31,817
| -43% | -$1.43M | ﹤0.01% | 4034 |
|
|
2015
Q2 | $3.38M | Buy |
73,717
+69,361
| +1,592% | +$3.29M | ﹤0.01% | 2949 |
|
|
2015
Q1 | $204K | Sell |
4,356
-10,809
| -71% | -$430K | ﹤0.01% | 4919 |
|
|
2014
Q4 | $480K | Buy |
15,165
+6,157
| +68% | +$180K | ﹤0.01% | 4650 |
|
|
2014
Q3 | $214K | Buy |
9,008
+1,200
| +15% | +$30.7K | ﹤0.01% | 5327 |
|
|
2014
Q2 | $234K | Sell |
7,808
-26,109
| -77% | -$704K | ﹤0.01% | 5410 |
|
|
2014
Q1 | $896K | Sell |
33,917
-37,401
| -52% | -$935K | ﹤0.01% | 4016 |
|
|
2013
Q4 | $1.79M | Buy |
71,318
+10,754
| +18% | +$240K | ﹤0.01% | 3422 |
|
|
2013
Q3 | $1.24M | Buy |
60,564
+764
| +1% | +$15.8K | ﹤0.01% | 3733 |
|
|
2013
Q2 | $1.19M | Buy |
+59,800
| New | +$1.06M | ﹤0.01% | 3829 |
|
Bank of America's IPXL Position: Q2 2018 in Review
Bank of America sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 227,221 shares — an estimated $4.42M sold.
Bank of America first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $4.42M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Bank of America reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Bank of America sold 227,221 Impax Laboratories, Inc. shares in Q2 2018, an estimated $4.42M.
- Bank of America first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Bank of America's Impax Laboratories, Inc. position peaked at $4.42M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.